Cytopia strengthens scientific team
This article was originally published in Scrip
Executive Summary
Cytopia (Australia) has appointed Dr Devron Averett chief scientific advisor. He will work closely with the company's executive management team, on a part-time basis during this year, to provide scientific leadership and guidance. He has held leadership roles at Glaxo Wellcome and Burroughs Wellcome and, in recent years, at Valeant Pharmaceuticals International and Anadys Pharmaceuticals, a company he co-founded. Cytopia is also consolidating its North American operations in Woodside, California, and closing the Rensselaer, New York, office, which is currently led by Dr Shreefal Mehta as vice-president of business and corporate development. Dr Mehta has chosen not to relocate to the west coast and will leave the company at the end of July. Richard Haiduck, who has been working with the company in a strategic consulting role, has been appointed as chief business advisor, with responsibility for Cytopia's global business and corporate development.